SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Monsanto Co. -- Ignore unavailable to you. Want to Upgrade?

To: jopawa who wrote (895)1/15/1999 6:09:00 PM
From: Anthony Wong  Read Replies (1) | Respond to of 2539
 
If Celebrex can't get a new-class label for Celebrex, its seems unlikely that Vioxx can get one. Anyway, that's at least 4 months away and it's an eternity in stock investing. If you've already got 500, better diversify by buying another drug stock. I suspect there's some more downside (double bottom?).

Celebrex should be out in the market soon. Hopefully we'll have some script no. soon to lift the stock price.

Anthony


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News